168 related articles for article (PubMed ID: 23614996)
21. Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.
Bourboulia D; Aldam D; Lagos D; Allen E; Williams I; Cornforth D; Copas A; Boshoff C
AIDS; 2004 Feb; 18(3):485-93. PubMed ID: 15090801
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
[TBL] [Abstract][Full Text] [Related]
23. Impact of Kaposi sarcoma-associated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHV ORF73 and ORF65 proteins.
Woodberry T; Suscovich TJ; Henry LM; Martin JN; Dollard S; O'Connor PG; Davis JK; Osmond D; Lee TH; Kedes DH; Khatri A; Lee J; Walker BD; Scadden DT; Brander C
J Infect Dis; 2005 Aug; 192(4):622-9. PubMed ID: 16028131
[TBL] [Abstract][Full Text] [Related]
24. Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
Guadalupe M; Pollock BH; Westbrook S; Redding S; Bullock D; Anstead G; Agan BK; Marconi VC; Barbieri S; Sankar V; Rebeles J; Flahive Y; Schoolfield J; Wang L; Lei X; Dow D; Yeh CK; Dang H; Infante AJ; Gao SJ
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):83-90. PubMed ID: 21084997
[TBL] [Abstract][Full Text] [Related]
25. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
26. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
[TBL] [Abstract][Full Text] [Related]
27. CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.
Vandormael A; Rego F; Danaviah S; Carlos Junior Alcantara L; Boulware DR; de Oliveira T
Curr HIV Res; 2017; 15(3):225-231. PubMed ID: 28215175
[TBL] [Abstract][Full Text] [Related]
28. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
Loutfy MR; Genebat M; Moore D; Raboud J; Chan K; Antoniou T; Milan D; Shen A; Klein MB; Cooper C; Machouf N; Rourke SB; Rachlis A; Tsoukas C; Montaner JS; Walmsley SL; Smieja M; Bayoumi A; Mills E; Hogg RS;
J Acquir Immune Defic Syndr; 2010 Dec; 55(4):451-9. PubMed ID: 21105259
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.
Gill J; Bourboulia D; Wilkinson J; Hayes P; Cope A; Marcelin AG; Calvez V; Gotch F; Boshoff C; Gazzard B
J Acquir Immune Defic Syndr; 2002 Dec; 31(4):384-90. PubMed ID: 12447008
[TBL] [Abstract][Full Text] [Related]
30. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
[TBL] [Abstract][Full Text] [Related]
31. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
[TBL] [Abstract][Full Text] [Related]
32. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
33. CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort.
Martinson NA; Gupte N; Msandiwa R; Moulton LH; Barnes GL; Ram M; Gray G; Hoffmann C; Chaisson RE
PLoS One; 2014; 9(5):e96369. PubMed ID: 24831447
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
35. The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children.
Soeters HM; Sawry S; Moultrie H; Rie AV
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):136-44. PubMed ID: 25072611
[TBL] [Abstract][Full Text] [Related]
36. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
37. Integration of antiretroviral therapy with tuberculosis treatment.
Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
[TBL] [Abstract][Full Text] [Related]
38. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients.
Portocarrero Nuñez JA; Gonzalez-Garcia J; Berenguer J; Gallego MJV; Loyarte JAI; Metola L; Bernal E; Navarro G; Del Amo J; Jarrín I;
Medicine (Baltimore); 2018 Sep; 97(38):e12238. PubMed ID: 30235668
[TBL] [Abstract][Full Text] [Related]
39. CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy.
Moore DM; Awor A; Downing R; Kaplan J; Montaner JS; Hancock J; Were W; Mermin J
J Acquir Immune Defic Syndr; 2008 Dec; 49(5):477-84. PubMed ID: 18989232
[TBL] [Abstract][Full Text] [Related]
40. KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection.
Parisi SG; Boldrin C; Andreis S; Ferretto R; Fuser R; Malena M; Manfrin V; Panese S; Scaggiante R; Dori L; Sarmati L; Biasolo MA; Nicastri E; Andreoni M; Cruciani M; Palù G
J Med Virol; 2011 Mar; 83(3):384-90. PubMed ID: 21264857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
